Labshake search
Citations for R&D Systems :
201 - 250 of 1998 citations for GM CSF Human HEK293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... USA) and cultured for 7 days with 20 ng/ml recombinant M-CSF (R&D Systems) to allow them to differentiate to macrophages ...
-
bioRxiv - Genetics 2023Quote: ... 0.2% PrimocinTM and macrophage colony-stimulating factor (M-CSF) (20 ng/mL; R&D systems; USA) and receptor activator of nuclear factor kappa-B ligand (RANKL ...
-
bioRxiv - Systems Biology 2023Quote: ... and 20 mM Hepes supplemented with recombinant mouse M-CSF (60 ng/ml; R&D Systems). BMDMs were scraped with cold PBS and plated in either a 48 or 96 well plate for qPCR and IF ...
-
bioRxiv - Immunology 2021Quote: ... biotinylated ACE2-hFc or mouse anti-His mAb (R&D systems). Spike trimer (1 µM binding sites ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were cultured in the presence of M-CSF (30 ng / mL; R&D Systems, Minneapolis, USA), and with RANKL (10 ng / mL ...
-
bioRxiv - Cell Biology 2021Quote: ... Osteoclast differentiation was induced by treatment with 25 ng/ml M-CSF (R&D Systems, Abingdon, UK) and 50 ng/ml RANKL (Peprotech ...
-
bioRxiv - Microbiology 2023Quote: ... to promote M1-differentiation or 20 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems) to promote M2-differentiation as previously described [9] ...
-
bioRxiv - Immunology 2024Quote: ... They were then incubated with recombinant M-CSF (50ng/ml) and rCHI3L1 (R&D Systems, 250ng/ml) alone or together ...
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesbioRxiv - Molecular Biology 2021Quote: ... 10 μg/mL anti-His tag antibody (clone AD1.1.10, R&D Systems), 50 ng/mL CpG ODN 2006 (Invivogen ...
-
bioRxiv - Immunology 2023Quote: ... 10 µg/mL anti-His tag antibody (clone AD1.1.10, R&D Systems), 50 ng/mL CpG ODN 2006 (Invivogen) ...
-
bioRxiv - Biochemistry 2023Quote: ... His-tagged ALS protein (R&D Systems, 10 ng/well, 1.5 µM) was immobilized in wells via neutravidin and the nickel-charged-NTA-decorated iBodies® (IOCB Tech ...
-
bioRxiv - Neuroscience 2020Quote: CSF-1 and IL-34 in plasma or brain were measured by commercially available immunoassays (R&D systems), according to manufacturer’s instructions.
-
bioRxiv - Immunology 2020Quote: ... CD14+ cells were differentiated with 20 ng/mL of macrophage colony-stimulating factor (M-CSF) (R&D systems) for 3 days followed by 3 days of polarization into naïve macrophages (M0 ...
-
bioRxiv - Neuroscience 2021Quote: ... HGF levels in CSF were measured by sandwich ELISA for HGF (DuoSet Kit, R&D Systems, Minneapolis, MN, USA), as described by the manufacturer ...
-
bioRxiv - Biochemistry 2020Quote: ... was mixed with 100 ng Tie2‐Fc (with His tag, R&D systems) in TBST buffer at 4°C for 4 hours ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems), or mouse IgG1 isotype antibodies (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... human fibronectin and human recombinant BMP-2 (R&D systems, Biotechne, UK); recombinant human BMP-2 (Infuse/InductOS® Bone graft kit ...
-
bioRxiv - Cell Biology 2020Quote: ... and differentiated in complete monocyte derived macrophage (MDM) medium containing 10 ng/ml M-CSF (R&D Systems, Abingdon, UK) for two days ...
-
bioRxiv - Neuroscience 2020Quote: ... The growth medium was replaced with DMEM supplemented with 2 ng/mL murine M-CSF (R&D Systems; Minneapolis, MN) and cultured in Nx for 3 or 6 days prior to LPS treatment.
-
bioRxiv - Microbiology 2021Quote: BMDM were isolated and differentiated in DMEM containing 20% FBS (Cytiva) and 25ng/ml rm-M-CSF (R&D Systems) as previously described [12] ...
-
bioRxiv - Cancer Biology 2023Quote: ... in High Glucose DMEM supplemented with 10% FBS and 10ng/mL Recombinant Mouse CSF-1 (R&D Systems, #416-ML) for 7 days.
-
bioRxiv - Neuroscience 2024Quote: ELISAs were used to quantify CTSB and CTSS levels in CSF (both R&D DuoSets, R&D Systems, Minneapolis, USA). CSF samples were diluted 20x with reagent diluent prior to ELISA analysis ...
-
bioRxiv - Genetics 2024Quote: His Tag Alexa Fluor® 488-conjugated Antibody Catalog #: IC050G from R&D systems. 2019-nCoV RBD ...
-
bioRxiv - Biophysics 2024Quote: ... Purified kinetochores were incubated with biotinylated α-His antibody (R&D Systems, Minneapolis MN) at an antibody concentration of 0.025 ng/µl for 1 hour at 4 °C with rotation ...
-
bioRxiv - Developmental Biology 2021Quote: ... human ACVR1 ECD fused to human G1 Fc (R&D Systems, 637-AR) and ACVR1 ECD (Creative Biomart ...
-
bioRxiv - Physiology 2023Quote: The human Proteome Profiler Human Phospho-Kinase Array Kit (#ARY003C, R&D Systems) was used to assess receptor phosphorylation and kinase activation of HCF treated with macrophages supernatants for 30 min ...
-
bioRxiv - Immunology 2023Quote: Recombinant Human IL-2 and human TGF-β were from R&D systems. Anti-mouse CD3 and biotin-anti-CD3 (145-2C11 ...
-
bioRxiv - Microbiology 2021Quote: ... and CD14+ monocytes were differentiated into macrophages (MDMs) using Macrophage-colony stimulatory factor (M-CSF) (R&D systems, Minneapolis, MN, USA) as previously described [20] ...
-
bioRxiv - Immunology 2022Quote: ... 5% CO2 for 8 days with 100 ng/ml macrophage colony-stimulating factor (M-CSF; R&D systems, cat.no 216-MC).
-
bioRxiv - Cancer Biology 2020Quote: ... Macrophage differentiation from bone marrow cells was obtained by culture in standard growth medium supplemented with m-CSF (R&D Systems) at 30 ng/ml for 7 days.
-
bioRxiv - Immunology 2020Quote: ... Neutrophil migration in response to UV light was inhibited by treating mice intraperitoneally (i.p.) with 50 μg anti-mouse G-CSF monoclonal antibody or mouse IgG isotype control (R&D Systems) 24h and 3h prior to skin exposure to UVB light (1 x 500 mJ/cm2 ...
-
bioRxiv - Immunology 2020Quote: ... and RPMI-1640 supplemented as described and with additional 20 mM Hepes and 25 ng/ml M-CSF (R&D Systems). Medium was changed every third day and the cells were allowed to differentiate for 10 days ...
-
bioRxiv - Immunology 2021Quote: ... CD14+HLA-DRneg/low/CD14+HLA-DRhigh monocytes were cultured in 96 well plates (200μL/well) in the presence of 20 ng/mL M-CSF (216-MC-005; R&D Systems) for 4 days.6 Monocyte-derived macrophages [(Mb) ...
-
bioRxiv - Cell Biology 2022Quote: ... 5% CO2 for 8 days with 100 ng/ml macrophage colony-stimulating factor (M-CSF; R&D systems, cat.no 216-MC). Fully differentiated macrophages were harvested and seeded at the required density for the subsequent experiments.
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... with or without 1.25 µg/mL Scl-Ab or 500 ng/mL anti-M-CSF antibody (#AF416 from R&D Systems). After 8 days ...
-
bioRxiv - Immunology 2022Quote: ... human IL-2 ELISA (human IL-2 Quantikine ELISA kit, R&D systems, USA) and TNFα ELISA (human TNF-alpha quantikine ELISA kit ...
-
bioRxiv - Cell Biology 2024Quote: Human colonic organoids were treated with recombinant human IL-22 protein (R&D Systems) at 10 ng/mL ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and Alexa Fluor 647® (AF647)-conjugated anti-His antibody (R&D Systems, catalog # IC0501R) or HER2-ED (R&D Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... human WNT3a (R&D Systems) and/or PI-88 (gift of Medigen Biotechnology Corp ...
-
bioRxiv - Immunology 2022Quote: ... and human (R&D Systems) ELISA kit by following the manufacturer’s instructions.
-
bioRxiv - Bioengineering 2020Quote: ... Human FN (R&D Systems) was adsorbed on the top of the surfaces by immersing them in 200 μl of a 20 μg/ml human plasma FN/PBS solution for 1 hr ...
-
bioRxiv - Cancer Biology 2023Quote: Human (R&D Systems, ARY005B) cytokine arrays were used ...
-
bioRxiv - Immunology 2023Quote: Human (R&D Systems, USA) and mouse IL-1α (R&D Systems ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were cultured in osteoclast medium supplemented with 10 ng/ml of M-CSF and 5 ng/ml of murine RANKL (R&D Systems) for 7-10 days ...
-
bioRxiv - Cell Biology 2020Quote: ... Bone marrow cells were plated in four replicates in 24-well plates at a density of 5 × 104 cells/well with 10 ng/ml of M-CSF (R&D Systems). Three days later ...
-
bioRxiv - Microbiology 2020Quote: ... Fully-differentiated MDM were generated by culturing MC under adherent conditions for seven days using RPMI-AS medium supplemented with 10 ng/mL M-CSF (R&D Systems). T cells were purified from PBMC using T cell pan isolation kit (Miltenyi Biotec) ...
-
bioRxiv - Cell Biology 2022Quote: ... and seeded in RPMI 1640 supplemented with 10% serum and 10 ng/ml recombinant macrophage colony-stimulating factor (M-CSF; R&D Systems) for 3 days ...
-
bioRxiv - Immunology 2019Quote: ... from wild type and Irak1−/− mice were prepared by differentiation for 6 days in the same culture medium containing macrophage colony-stimulating factor (M-CSF; 60 ng/mL, R&D Systems). LPS was from Alexis Biochemicals (Salmonella minnesota R595 TLR grade ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were kept in serum-free medium for 4 hours prior to stimulation and then incubated with recombinant CSF-1 or IL-34 (R&D Systems) for the indicated time points ...
-
bioRxiv - Immunology 2020Quote: ... in serum-free medium (5 x 106/4 ml of AIM-V) supplemented with M-CSF (50 ng/ml; R&D Systems) over 7 days followed by 18 h treatment with IFN-γ (20 ng/ml ...